Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Public-private interaction in pharmaceutical research

I Cockburn1, R Henderson

  • 1Faculty of Commerce and Business Administration, University of British Columbia, Vancouver, Canada.

Proceedings of the National Academy of Sciences of the United States of America
|November 12, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

First Measurement of Time-Dependent CP Violation in the Flavor-Changing Neutral-Current Decay B^{0}→K_{S}^{0}μ^{+}μ^{-}.

Physical review letters·2026
Same author

Measurement of the Top-Quark Production Cross Section and Charge Asymmetry at LHCb.

Physical review letters·2026
Same author

Targeted degradation of CBP/p300 by CBPD-409 exhibits robust anti-myeloma activity.

Leukemia·2026
Same author

Searches for B^{0}→K^{+}π^{-}τ^{+}τ^{-} and B_{s}^{0}→K^{+}K^{-}τ^{+}τ^{-} Decays.

Physical review letters·2026
Same author

First Evidence of the B_{s}^{0}→K^{-}π^{+}γ Decay.

Physical review letters·2026
Same author

Precision Measurement of CP Violation and Branching Fractions in B^{±}→K_{S}^{0}h^{±} (h=π, K) Decays and Search for the Rare Decay B_{c}^{±}→K_{S}^{0}K^{±}.

Physical review letters·2026

Public and private sectors interact significantly in pharmaceutical research, challenging linear models. Firm-specific linkages to public research influence their innovation performance.

Area of Science:

  • Pharmaceutical research
  • Biotechnology innovation
  • Science and technology studies

Background:

  • Traditional models depict public sector basic research as separate from private sector applied research.
  • Understanding the dynamics of public-private partnerships is crucial for optimizing pharmaceutical innovation.
  • The role of inter-sectoral collaboration in drug discovery remains an area requiring empirical investigation.

Purpose of the Study:

  • To empirically investigate the nature and extent of interaction between public and private sectors in pharmaceutical research.
  • To challenge and reject a simplistic linear model of public basic research and private sector exploitation.
  • To explore how firm-specific factors influence public-private linkages and correlate with research performance.

Main Methods:

Related Experiment Videos

  • Qualitative analysis of the drug discovery process.
  • Quantitative analysis of coauthorship incidence between public and private institutions.
  • Comparative case studies of firms with varying public-private linkages.

Main Results:

  • Evidence of significant reciprocal interaction between public and private sectors in pharmaceutical research.
  • Rejection of a linear model where public research solely feeds private exploitation.
  • Identification of differential linkages to the public sector across firms, influenced by internal incentives and policy.
  • Correlation between the nature of these linkages and firms' research performance.

Conclusions:

  • The interaction between public and private sectors in pharmaceutical research is complex and reciprocal, not linear.
  • Firms' strategic choices and internal incentives shape their engagement with the public sector.
  • Tailored public-private collaborations are associated with enhanced research performance in the pharmaceutical industry.